Panbela Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Panbela Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Panbela Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 4.85M shares, a 3232% increase year-over-year.
  • Panbela Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 109K shares, a 87.1% decline from 2022.
  • Panbela Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 845K shares, a 189% increase from 2021.
  • Panbela Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 293K shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 4.85M +4.71M +3232% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 4.85M +4.82M +13147% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 3.13M +3.11M +23912% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 109K -736K -87.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 146K +129K +752% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 36.7K +24.6K +205% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 13K -323K -96.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 845K +552K +189% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 17.1K -13.3M -99.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 12K -10.1M -99.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 336K -9.55M -96.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 293K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 13.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 10.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 9.89M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.